These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16646077)

  • 1. Clinically tolerable concentrations of arsenic trioxide induce p53-independent cell death and repress NF-kappa B activation in Ewing sarcoma cells.
    Mathieu J; Besançon F
    Int J Cancer; 2006 Oct; 119(7):1723-7. PubMed ID: 16646077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
    Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
    J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
    Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-kappa B.
    Javelaud D; Besançon F
    Oncogene; 2001 Jul; 20(32):4365-72. PubMed ID: 11466617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide concentration determines the fate of Ewing's sarcoma family tumors and neuroblastoma cells in vitro.
    Jung HS; Kim HS; Lee MJ; Shin HY; Ahn HS; Ryu KH; Seoh JY; Kim CJ; Jang JJ
    FEBS Lett; 2006 Sep; 580(20):4969-75. PubMed ID: 16930595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway.
    Scholz C; Wieder T; Stärck L; Essmann F; Schulze-Osthoff K; Dörken B; Daniel PT
    Oncogene; 2005 Mar; 24(11):1904-13. PubMed ID: 15674346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of leukemic T-cell lines to arsenic trioxide cytotoxicity is dependent on the induction of phosphatase B220/CD45R expression at the cell surface.
    Benbijja M; Mellouk A; Bobé P
    Mol Cancer; 2014 Nov; 13():251. PubMed ID: 25410152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide inhibits cell growth in SH-SY5Y and SK-N-AS neuroblastoma cell lines by a different mechanism.
    Woo SY; Lee MY; Jung YJ; Yoo ES; Seoh JY; Shin HY; Ahn HS; Ryu KH
    Pediatr Hematol Oncol; 2006; 23(3):231-43. PubMed ID: 16517539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide potentiates the effectiveness of etoposide in Ewing sarcomas.
    Boehme KA; Nitsch J; Riester R; Handgretinger R; Schleicher SB; Kluba T; Traub F
    Int J Oncol; 2016 Nov; 49(5):2135-2146. PubMed ID: 27665785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide represses NF-kappaB activation and increases apoptosis in ATRA-treated APL cells.
    Mathieu J; Besançon F
    Ann N Y Acad Sci; 2006 Dec; 1090():203-8. PubMed ID: 17384263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
    Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
    Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of hTERT: an important As2O3 induced mechanism of apoptosis in myelodysplastic syndrome.
    Xu W; Wang Y; Tong H; Qian W; Jin J
    PLoS One; 2014; 9(11):e113199. PubMed ID: 25415199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide decreases AKT protein in a caspase-dependent manner.
    Mann KK; Colombo M; Miller WH
    Mol Cancer Ther; 2008 Jun; 7(6):1680-7. PubMed ID: 18566239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
    Park MJ; Lee JY; Kwak HJ; Park CM; Lee HC; Woo SH; Jin HO; Han CJ; An S; Lee SH; Chung HY; Park IC; Hong SI; Rhee CH
    J Cell Biochem; 2005 Aug; 95(5):955-69. PubMed ID: 15962302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage.
    Mahieux R; Pise-Masison C; Gessain A; Brady JN; Olivier R; Perret E; Misteli T; Nicot C
    Blood; 2001 Dec; 98(13):3762-9. PubMed ID: 11739184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C).
    Michel L; Dupuy A; Jean-Louis F; Sors A; Poupon J; Viguier M; Musette P; Dubertret L; Degos L; Dombret H; Bachelez H
    J Invest Dermatol; 2003 Oct; 121(4):881-93. PubMed ID: 14632209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide-induced apoptosis of human malignant lymphoma cell lines and its mechanisms.
    Lu D; Bai XC; Gui L; Li M; Zheng WS; Han XQ; Luo SQ
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):997-1001. PubMed ID: 14559676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells.
    Kang YH; Lee SJ
    J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells.
    Seol JG; Park WH; Kim ES; Jung CW; Hyun JM; Lee YY; Kim BK
    Int J Oncol; 2001 Feb; 18(2):249-55. PubMed ID: 11172589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway.
    Scholz C; Richter A; Lehmann M; Schulze-Osthoff K; Dörken B; Daniel PT
    Oncogene; 2005 Oct; 24(47):7031-42. PubMed ID: 16007134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.